nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients
|
Seong, Moon-Woo |
|
2014 |
146 |
1 |
p. 63-69 |
artikel |
2 |
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer
|
Tu, Yifan |
|
2014 |
146 |
1 |
p. 145-152 |
artikel |
3 |
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI
|
Lintermans, A. |
|
2014 |
146 |
1 |
p. 109-116 |
artikel |
4 |
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer
|
Ambros, Tadeu |
|
2014 |
146 |
1 |
p. 7-14 |
artikel |
5 |
Body mass index, diabetes, and triple-negative breast cancer prognosis
|
Tait, Sarah |
|
2014 |
146 |
1 |
p. 189-197 |
artikel |
6 |
Breast cancer and aging: results of the U13 conference breast cancer panel
|
Barginear, M. F. |
|
2014 |
146 |
1 |
p. 1-6 |
artikel |
7 |
Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071
|
Liang, Yayun |
|
2014 |
146 |
1 |
p. 51-62 |
artikel |
8 |
Determining axillary concordance rate for different injection locations in sentinel node mapping of breast cancer: how ambitious can we get?
|
Sadeghi, Ramin |
|
2014 |
146 |
1 |
p. 231-232 |
artikel |
9 |
Early myocardial deformation abnormalities in breast cancer survivors
|
Bulten, Ben F. |
|
2014 |
146 |
1 |
p. 127-135 |
artikel |
10 |
Erratum to: The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis
|
Carlson, Josh J. |
|
2014 |
146 |
1 |
p. 233 |
artikel |
11 |
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
|
Muenst, S. |
|
2014 |
146 |
1 |
p. 15-24 |
artikel |
12 |
HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer
|
Pillai, Manoj M. |
|
2014 |
146 |
1 |
p. 85-97 |
artikel |
13 |
Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors
|
Sizemore, Steven T. |
|
2014 |
146 |
1 |
p. 25-40 |
artikel |
14 |
Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells
|
Katz, Tiffany A. |
|
2014 |
146 |
1 |
p. 99-108 |
artikel |
15 |
Mortality outcome among medically underserved women screened through a publicly funded breast cancer control program, 1997–2007
|
Bhuyan, Soumitra Sudip |
|
2014 |
146 |
1 |
p. 221-227 |
artikel |
16 |
Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells
|
Liu, Chun-Yu |
|
2014 |
146 |
1 |
p. 71-84 |
artikel |
17 |
Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers
|
Tung, Nadine |
|
2014 |
146 |
1 |
p. 175-182 |
artikel |
18 |
Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients
|
Arce-Salinas, C. |
|
2014 |
146 |
1 |
p. 183-188 |
artikel |
19 |
Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
|
Madhavan, Dharanija |
|
2014 |
146 |
1 |
p. 163-174 |
artikel |
20 |
Quality of life and patient satisfaction after microsurgical abdominal flap versus staged expander/implant breast reconstruction: a critical study of unilateral immediate breast reconstruction using patient-reported outcomes instrument BREAST-Q
|
Liu, Chunjun |
|
2014 |
146 |
1 |
p. 117-126 |
artikel |
21 |
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study
|
Clemons, Mark J. |
|
2014 |
146 |
1 |
p. 153-162 |
artikel |
22 |
Sentinel lymph node identification rates and axillary concordance can only be accurately determined by comparing ‘like with like’ injected materials
|
Ahmed, Muneer |
|
2014 |
146 |
1 |
p. 229-230 |
artikel |
23 |
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data
|
Haricharan, Svasti |
|
2014 |
146 |
1 |
p. 211-220 |
artikel |
24 |
The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer
|
Sabatino, Susan A. |
|
2014 |
146 |
1 |
p. 199-209 |
artikel |
25 |
The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster
|
Jin, Lianjin |
|
2014 |
146 |
1 |
p. 41-50 |
artikel |
26 |
Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen
|
Jager, N. G. L. |
|
2014 |
146 |
1 |
p. 137-144 |
artikel |